Ascendis Pharma A (ASND) Long-Term Debt Issuances (2022 - 2023)

Ascendis Pharma A has reported Long-Term Debt Issuances for 2 years, with the latest figure at -$3.8 million in Q4 2023.

• Quarterly Long-Term Debt Issuances changed N/A year-over-year to -$3.8 million in Q4 2023, while the trailing twelve-month figure through Dec 2025 was $148.4 million (changed 0.0% YoY) and the FY2024 annual result came in at $143.4 million, down 2.73% from the prior year.
• Long-Term Debt Issuances slipped to -$3.8 million in Q4 2023 per ASND's latest filing, from $152.2 million in the prior quarter.
• Over five years, Long-Term Debt Issuances peaked at $566.2 million in Q1 2022 and troughed at -$3.8 million in Q4 2023.